Top 5 Weight Loss Medications That Work

If you have struggled to lose weight through diet and exercise alone, you are not alone. For some adults with obesity or overweight plus a related health condition, FDA-approved weight loss medications may be a helpful part of a physician-supervised treatment plan.

This guide covers seven medications the FDA has approved for weight management, including newer options like Zepbound and oral semaglutide. All of these require a prescription and physician oversight. They are not quick fixes, but when combined with the right lifestyle changes and a personalized care plan, they may help some patients achieve meaningful, sustainable results.

This article is for educational purposes only and does not replace personalized medical advice. Always consult a qualified physician before starting or stopping any medication.

Who May Qualify for Prescription Weight Loss Treatment?

Weight loss medications are not right for everyone, and they are not prescribed to help someone lose a few pounds before a vacation. Physicians typically consider prescribing weight-loss treatment for adults who meet certain criteria.

You may be a candidate if you:

• Have a BMI of 30 or higher (classified as obesity)
• Have a BMI of 27 or higher, plus at least one weight-related condition such as high blood pressure, type 2 diabetes, or sleep apnea
• Have already tried structured lifestyle changes, including diet and increased physical activity, without achieving adequate results
• Are committed to ongoing physician follow-up, monitoring, and a long-term care plan

Your physician at Hillside Primary Care will review your full health history, BMI, existing conditions, and goals before recommending any medication.

Quick Comparison: 7 FDA-Approved Weight Loss Medications

Top 7 Weight Loss Medications That Are Safe: In Detail

For those wishing to learn more about their options, the following list highlights 7 of the most useful weight-loss medications that are safe and also FDA (Food and Drug Administration Department) certified:

1. Orlistat (Alli / Xenical)

• What it is: Orlistat is one of the longest-acting FDA-approved weight-loss medications. It is sold over the counter as Alli and by prescription as Xenical.
• How it works: It inhibits lipase, an enzyme that breaks down dietary fat in the intestines. Reducing fat absorption lowers the total caloric intake from fat.
• Who it may help: Adults who are looking for a non-stimulant, non-injection option and are willing to follow a low-fat diet during treatment.
• Common side effects: Oily or loose stools, increased bowel movements, and stomach discomfort, especially when eating high-fat foods. These side effects are the most common reason patients stop taking it.
• Key limitation: Orlistat works best with a disciplined low-fat diet. It is not the most potent option available today, but it is the only FDA-approved weight loss medication sold without a prescription at a lower dose.

2. Phentermine

• What it is: Phentermine is a prescription stimulant that has been in use for decades. It is one of the most commonly prescribed weight loss medications in the United States.
• How it works: It affects brain chemicals that regulate appetite, helping to reduce hunger and lower overall caloric intake.
• Who it may help: Adults who need short-term appetite support as part of a broader weight management plan.
• Common side effects: Elevated heart rate, increased blood pressure, insomnia, dry mouth, and nervousness.
• Key limitation: Phentermine is typically prescribed for short-term use only. It is not suitable for patients with heart conditions, hypertension, or a history of certain conditions. Your physician will assess your cardiovascular history before considering it.

3. Phentermine/Topiramate (Qsymia)

• What it is: Qsymia is a prescription combination pill that pairs phentermine (an appetite suppressant) with topiramate (an anticonvulsant that also helps reduce hunger and cravings).
• How it works: The two medications work together to reduce appetite and increase feelings of fullness, helping patients eat less over time.
• Who it may help: Adults who need longer-term appetite management through an oral medication rather than an injection, and who are good candidates based on their full health profile.
• Common side effects: Tingling in hands or feet, dry mouth, constipation, insomnia, and potential mood changes. Not appropriate for pregnancy.
• Key limitation: Topiramate carries risks for certain patients and the combination requires careful screening and ongoing follow-up. Patients need to be monitored regularly during treatment.

4. Naltrexone/Bupropion (Contrave)

• What it is: Contrave is a combination prescription pill that pairs naltrexone (used for addiction treatment) and bupropion (used for depression and smoking cessation) in lower doses to support weight management.
• How it works: Together, the two components act on brain pathways that influence appetite, food cravings, and reward-driven eating behaviors. Many patients notice a reduction in the urge to overeat or reach for food emotionally.
• Who it may help: Adults who struggle with cravings and emotional eating as a major driver of weight gain, and who have a suitable health profile for both medications.
• Common side effects: Nausea, headache, dizziness, constipation, and dry mouth. Nausea is the most commonly reported, especially early in treatment.
• Key limitation: Contrave is not appropriate for patients with seizure disorders or who are currently taking monoamine oxidase inhibitors (MAOIs). As with all medications here, physician supervision is essential.

5. Liraglutide (Saxenda)

• What it is: Saxenda is a once-daily injectable prescription medication that belongs to a class called GLP-1 receptor agonists. It was approved for chronic weight management in adults with obesity or overweight plus a weight-related condition.
• How it works: It mimics a hormone called glucagon-like peptide-1 (GLP-1) that signals fullness to the brain, slowing digestion and reducing appetite. Over time, patients typically feel full on less food.
• Who it may help: Adults who need a physician-supervised injection-based option, particularly those who have already been managed on GLP-1 therapy or who are not candidates for newer weekly options.
• Common side effects: Nausea, vomiting, diarrhea, and constipation, particularly in the early weeks of treatment as doses are gradually increased.
• Key limitation: Saxenda is a daily injection, which some patients find less convenient than the weekly options now available. Discuss with your physician whether a daily or weekly GLP-1 is more appropriate for your lifestyle.

6. Semaglutide (Wegovy)

• What it is: Wegovy is a weekly injectable prescription medication that is FDA-approved specifically for chronic weight management. It belongs to the same GLP-1 receptor agonist class as Saxenda, but is a different medication taken at a different dose and frequency.Note: Ozempic is a different brand of semaglutide FDA-approved for type 2 diabetes management, not for weight loss. Wegovy is the FDA-approved brand for weight management.
• How it works: Like liraglutide, it activates GLP-1 receptors to reduce appetite and slow gastric emptying. Patients on Wegovy typically experience reduced hunger and improved control over portion sizes over time.
• Who it may help: Adults with obesity or overweight plus a related condition who are ready for a physician-supervised, once-weekly injection program.
• Common side effects: Nausea, diarrhea, constipation, vomiting, and stomach discomfort. These tend to reduce as patients adjust to the medication.
• Key limitation: Wegovy is a long-term commitment. Stopping it without a physician-guided plan may affect results. It is most effective when combined with lifestyle changes, including dietary improvements and regular physical activity.

7. Tirzepatide (Zepbound)

• What it is: Zepbound is a weekly injectable prescription medication FDA-approved for chronic weight management in adults with obesity or overweight plus at least one weight-related condition. It is one of the newer additions to the FDA-approved obesity treatment landscape.
• How it works: Unlike the GLP-1-only medications above, tirzepatide activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors. This dual action affects multiple pathways involved in appetite regulation and energy intake.
• Who it may help: Adults with an eligible BMI and at least one weight-related health condition who are working with a physician on a long-term obesity treatment plan. Your doctor will determine if Zepbound is appropriate based on your full health profile.
• Common side effects: Nausea, diarrhea, vomiting, constipation, and stomach pain, most commonly during dose escalation in the early weeks.
• Key limitation: As with all obesity medications, Zepbound works best as part of a comprehensive program that includes dietary changes, increased physical activity, and ongoing physician monitoring.

8. Oral Semaglutide (Wegovy Pill)

• What it is: In December 2025, the FDA approved an oral form of semaglutide for chronic weight management, marking the first oral GLP-1 receptor agonist approved for weight loss. This is a once-daily pill option for adults who would prefer not to use injections.
• How it works: The same GLP-1 pathway as injectable semaglutide, reducing appetite and promoting feelings of fullness, but delivered in pill form.
• Who it may help: Adults who qualify for GLP-1 therapy but prefer an oral option over a weekly injection. This may be a meaningful option for eligible patients with needle aversion or lifestyle preferences that favor daily pills over injections.
• Common side effects: Similar to injectable semaglutide, nausea, diarrhea, constipation, and GI discomfort, particularly early in treatment.
• Key limitation: This is a newer approved option, and patient selection remains physician-guided. It is not interchangeable with injectable semaglutide without a physician’s direction.

How Doctors Choose the Right Medication

There is no single “best” weight loss medication. What works well for one patient may not be appropriate for another. At Hillside Primary Care, your physician will assess:

• Your BMI and any weight-related health conditions
• Your cardiovascular history and blood pressure
• Whether you prefer a daily pill, weekly injection, or daily injection
• Your history with previous weight management approaches
• Potential drug interactions with medications you already take
• Insurance coverage and medication access
• Your long-term commitment to follow-up and lifestyle changes

This is a conversation, not a prescription list. Book a medical weight loss consultation, and your doctor will help you understand which, if any, of these options may be appropriate for your situation.

Side Effects and Safety: What to Keep in Mind

All FDA-approved weight-loss medications have potential side effects, and safety depends heavily on an individual’s health history. Here are four things every patient should understand before starting treatment:

• GI side effects are common with GLP-1 medications (semaglutide, liraglutide, tirzepatide) and typically decrease over several weeks as the body adjusts.
• Not every medication is suitable for every patient. Heart conditions, pregnancy, mental health history, and current medications all affect which options are safe.
• Ongoing monitoring matters. Dose adjustments, lab work, and regular check-ins help ensure the medication is working appropriately and tolerability is maintained.
• These medications are part of a plan, not a standalone solution. Every FDA-approved obesity medication is intended to be used alongside improved nutrition, increased physical activity, and physician follow-up.

This article is for educational purposes only. It does not replace the advice of a licensed physician who knows your full medical history.

Medication Works Best With Lifestyle Changes

Weight loss medications support your efforts; they do not replace them. Research consistently shows that patients who achieve the best long-term outcomes combine medication with sustainable behavioral changes. That means a nutritious eating pattern, consistent physical activity appropriate for your health level, adequate sleep, and stress management.

If you stop medication without also building lasting habits, maintaining your progress can be difficult. Your physician and care team can help you develop a plan that doesn’t rely solely on medication for long-term success. Visit our weight loss tips resource for practical guidance you can start today.

Frequently Asked Questions:

1. What weight loss medications are FDA-approved in 2026?

   As of 2026, FDA-approved prescription weight loss medications include orlistat (Xenical/Alli), phentermine, phentermine/topiramate (Qsymia), naltrexone/bupropion (Contrave), liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound), and oral semaglutide (Wegovy pill, approved December 2025). Your doctor will determine which, if any, are appropriate for you.

2. What is the difference between Wegovy and Zepbound?

   Both are weekly injectable prescription medications for chronic weight management, but they work differently. Wegovy contains semaglutide and activates GLP-1 receptors only. Zepbound contains tirzepatide and activates both GLP-1 and GIP receptors. Your physician will evaluate your individual profile to discuss which may be suitable.

3. Is there now an oral weight loss medication similar to Wegovy?

   Yes. In December 2025, the FDA approved an oral form of semaglutide for chronic weight management. This once-daily pill works through the same GLP-1 pathway as injectable Wegovy and may be a suitable option for patients who prefer a pill over injections. Speak with your physician to determine eligibility.

4. Are weight loss pills or injections more effective?

   Effectiveness depends on the medication and the patient, not the format alone. Newer injectable options like Wegovy and Zepbound have demonstrated significant weight loss in clinical trials. However, the “best” option is always the one that is medically appropriate for you, that you can tolerate, and that you can sustain long-term.

5. Who qualifies for prescription weight loss medication?

   Physicians typically consider prescription weight loss medication for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as type 2 diabetes, hypertension, or sleep apnea, especially when lifestyle modifications alone have not been sufficient.

6. What are the most common side effects of weight loss medications?

   The most common side effects vary by medication, but GI symptoms, including nausea, diarrhea, constipation, and stomach discomfort, are frequently reported with GLP-1 medications. Phentermine-based medications may cause elevated heart rate and blood pressure. All side effects should be discussed with your prescribing physician.

7. Can I take weight loss medication without changing my diet or exercise habits?

   Technically, yes, but results are significantly better when medication is paired with lifestyle changes. All FDA-approved weight loss medications are intended to be used alongside a reduced-calorie diet and increased physical activity. Medication alone rarely delivers lasting results.

8. How long do people typically stay on weight loss medication?

   This varies by medication and patient. Some, like phentermine, are typically short-term. GLP-1-based medications like Wegovy and Zepbound are designed for longer-term, physician-supervised use. Your doctor will set a plan based on your progress, tolerability, and goals.

Ready to Explore Your Options?

If you have been struggling to lose weight despite genuine effort, a supervised medical weight loss program may help. At Hillside Primary Care, our physicians evaluate each patient individually and build a plan that may include medication, nutritional guidance, and activity recommendations tailored to your health history.

Book a Weight Loss Consultation or call us at (210) 742-6555 to speak with a member of our care team. We serve patients across multiple locations in Texas, and we accept most major insurance plans.